Inclusion Criteria:

• * Ambulatory adult subjects (\> 21 years of age) of either gender of any ethnicity
• * Must have taken PPI (omeprazole or equivalent ≥ 20 mg/day, ≥ three times per week, for at least 2 months)
• * Expected to continue at a similar dosage
• * Stage 1 hypertension (with systolic blood pressure \<140 and diastolic \<90)
• * Controlled diabetes mellitus Type II with HbA1C less than 7%

Exclusion Criteria:

• * End-stage renal failure on dialysis
• * Hypercalcemia,
• * Hypophosphatemia (serum P \< 2.5 mg/dL)
• * Hypertension stage 2 or higher
• * Diabetes Type II with HbA1C ≥ 7%
• * Treatment with adrenocorticosteroids, diuretics, non-steroidal anti-inflammatory agents - - Regular dose of magnesium supplements, bisphosphonate, teriparatide, denosumab or selective estrogen receptor modulators
• * Required to take calcium
• Inclusion/exclusion of other drugs or conditions will be considered on an individual basis.